ROVA-T Trademark

Trademark Overview

On Friday, March 8, 2019, a trademark application was filed for ROVA-T with the United States Patent and Trademark Office. The USPTO has given the ROVA-T trademark a serial number of 88331883. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 4, 2022. This trademark is owned by AbbVie Stemcentrx LLC. The ROVA-T trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

providing medical and scientific research information in the field of pharmaceuticals and clinical trials
rova-t

General Information

Serial Number88331883
Word MarkROVA-T
Filing DateFriday, March 8, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 4, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2019

Trademark Statements

Goods and Servicesproviding medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 27, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbbVie Stemcentrx LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNorth Chicago, IL 60064
Party NameAbbVie Stemcentrx LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNorth Chicago, IL 60064

Trademark Events

Event DateEvent Description
Monday, April 4, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 4, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 22, 2021SOU EXTENSION 4 GRANTED
Thursday, July 22, 2021SOU EXTENSION 4 FILED
Thursday, July 22, 2021SOU TEAS EXTENSION RECEIVED
Thursday, March 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 2, 2021SOU EXTENSION 3 GRANTED
Tuesday, March 2, 2021SOU EXTENSION 3 FILED
Tuesday, March 2, 2021SOU TEAS EXTENSION RECEIVED
Thursday, September 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 1, 2020SOU EXTENSION 2 GRANTED
Tuesday, September 1, 2020SOU EXTENSION 2 FILED
Tuesday, September 1, 2020SOU TEAS EXTENSION RECEIVED
Saturday, February 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 19, 2020SOU EXTENSION 1 GRANTED
Wednesday, February 19, 2020SOU EXTENSION 1 FILED
Wednesday, February 19, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, February 19, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 19, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 19, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 3, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 19, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 3, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 3, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 3, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 30, 2019ASSIGNED TO LIE
Friday, May 24, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 23, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 23, 2019NON-FINAL ACTION E-MAILED
Thursday, May 23, 2019NON-FINAL ACTION WRITTEN
Friday, May 17, 2019ASSIGNED TO EXAMINER
Wednesday, March 27, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 12, 2019NEW APPLICATION ENTERED

Related Keywords

rova pharmaceuticals clinical trials field information medical scientific research providing